mimic glp 1 GLP-1 Agonists - What is it? GLP-1 Drugs to Reduce Symptoms
Description
Six and a half decades of staying ahead
The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field
Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Robert Kushner, who helped bring them to market, breaks down how they actually work, who benefits most, and why they're a long-term commitment rather than a quick fix.
Green tea, gymnema, turmeric, and B vitamins provide antioxidant and metabolic support
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has revolutionized the treatment of Type 2 Diabetes Mellitus (T2DM)
